Your account is not claimed yet. You can sign up with ORCID to claim your account.

Anna-Maria Dittrich (Anna M Dittrich)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 13

Top Venues

The European respiratory journal

American journal of respiratory and critical care medicine

ERJ open research

Clinical & translational immunology

Hannover Medical School

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hannover Medical School Aug 1o 2007

Germany

physician :: Pediatric Pneumology, Allergology and Neonatology

Publications

Felix C C Ringshausen, Annette Sauer-Heilborn, Tina Büttner, Anna-Maria Dittrich, Nicolaus Schwerk, Fabio Ius, Lutz Nährlich, Tobias Welte, Mark Greer
Lung transplantation for end-stage cystic fibrosis before and after the availability of elexacaftor-tezacaftor-ivacaftor, Germany, 2012-2021. The European respiratory journal 61 (1) (2023)
Mirjam Stahl, Jobst Roehmel, Monika Eichinger, Felix Doellinger, Lutz Naehrlich, Matthias V Kopp, Anna-Maria Dittrich, Christopher Lee, Olaf Sommerburg, Simon Tian, Tu Xu, Pan Wu, Aniket Joshi, Partha Ray, Margaret E Duncan, Mark Oliver Wielpütz, Marcus Alexander Mall
Effects of Lumacaftor/Ivacaftor on Cystic Fibrosis Disease Progression in Children 2 through 5 Years of Age Homozygous for F508del-CFTR: A Phase 2 Placebo-controlled Clinical Trial. Annals of the American Thoracic Society (2023)
Azam Salari, Renjie Xiu, Mahdi Amiri, Sophia Theres Pallenberg, Rainer Schreiber, Anna-Maria Dittrich, Burkhard Tümmler, Karl Kunzelmann, Ursula E Seidler
The Anion Channel TMEM16a/Ano1 Modulates CFTR Activity, but Does Not Function as an Apical Anion Channel in Colonic Epithelium from Cystic Fibrosis Patients and Healthy Individuals. International journal of molecular sciences 24 (18) (2023)
Felix C C Ringshausen, Annette Sauer-Heilborn, Tina Büttner, Anna-Maria Dittrich, Nicolaus Schwerk, Fabio Ius, Lutz Nährlich, Tobias Welte, Mark Greer
Lung transplantation for end-stage cystic fibrosis before and after the availability of elexacaftor-tezacaftor-ivacaftor, Germany, 2012-2021. The European respiratory journal 61 (1) (2023)
Felix C C Ringshausen, Annette Sauer-Heilborn, Tina Büttner, Anna-Maria Dittrich, Nicolaus Schwerk, Fabio Ius, Lutz Nährlich, Tobias Welte, Mark Greer
Lung transplantation for end-stage cystic fibrosis before and after the availability of elexacaftor-tezacaftor-ivacaftor, Germany, 2012-2021. The European respiratory journal 61 (1) (2023)
Jessica Rademacher, Luise Martin, Anja Theloe, Mirjam Stahl, Marcus Alexander Mall, Oana Joean, Jan Fuge, Gesine Hansen, Tobias Welte, Katharina Schütz, Felix C C Ringshausen, Anna-Maria Dittrich
Optimal treatment of the underlying aetiology is the most effective antimicrobial stewardship for chronic respiratory disease: a lesson learned from cystic fibrosis. ERJ open research 9 (4) (2023)
Simon Y Graeber, Diane M Renz, Mirjam Stahl, Sophia T Pallenberg, Olaf Sommerburg, Lutz Naehrlich, Julian Berges, Martha Dohna, Felix C Ringshausen, Felix Doellinger, Constanze Vitzthum, Jobst Röhmel, Christine Allomba, Susanne Hämmerling, Sandra Barth, Claudia Rückes-Nilges, Mark Oliver Wielpütz, Gesine Hansen, Jens Vogel-Claussen, Burkhard Tümmler, Marcus Alexander Mall, Anna-Maria Dittrich
Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on Lung Clearance Index and Magnetic Resonance Imaging in Patients with Cystic Fibrosis and One or Two F508del Alleles. American journal of respiratory and critical care medicine 206 (3) (2022)
Anna-Maria Dittrich, Sandra Y Chuang
Dual CFTR modulator therapy efficacy in the real world: lessons for the future. ERJ open research 8 (4) (2022)
Melanie Albrecht, Olga Halle, Svenja Gaedcke, Sophia T Pallenberg, Julia Camargo Neumann, Marius Witt, Johanna Roediger, Marina Schumacher, Adan Chari Jirmo, Gregor Warnecke, Danny Jonigk, Peter Braubach, David DeLuca, Gesine Hansen, Anna-Maria Dittrich
Interleukin-17A and interleukin-22 production by conventional and non-conventional lymphocytes in three different end-stage lung diseases. Clinical & translational immunology 11 (6) (2022)
Simon Y Graeber, Constanze Vitzthum, Sophia T Pallenberg, Lutz Naehrlich, Mirjam Stahl, Alexander Rohrbach, Marika Drescher, Rebecca Minso, Felix C Ringshausen, Claudia Rueckes-Nilges, Jan Klajda, Julian Berges, Yin Yu, Heike Scheuermann, Stephanie Hirtz, Olaf Sommerburg, Anna-Maria Dittrich, Burkhard Tümmler, Marcus Alexander Mall
Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on CFTR Function in Patients with Cystic Fibrosis and One or Two F508del Alleles. American journal of respiratory and critical care medicine 205 (5) (2022)
Felix C C Ringshausen, Annette Sauer-Heilborn, Tina Büttner, Anna-Maria Dittrich, Nicolaus Schwerk, Fabio Ius, Lutz Nährlich, Tobias Welte, Mark Greer
Lung transplantation for end-stage cystic fibrosis before and after the accessibility of elexacaftor/tezacaftor/ivacaftor, Germany, 2012-2021. The European respiratory journal (2022)
Dominik Funken, Ursula Schmidtmayer, Martin Durisin, Danny Jonigk, Ulrich Baumann, Anna-Maria Dittrich
Listen Carefully: The Hairy Polyp as an Unusual Cause of Neonatal Stridor. American journal of respiratory and critical care medicine 200 (7) (2020)
Isa Rudolf, Katharina Pieper, Helga Nolte, Sibylle Junge, Christian Dopfer, Annette Sauer-Heilborn, Felix C C Ringshausen, Burkhard Tümmler, Ute von Jan, Urs-Vito Albrecht, Jan Fuge, Gesine Hansen, Anna-Maria Dittrich
Assessment of a Mobile App by Adolescents and Young Adults With Cystic Fibrosis: Pilot Evaluation. JMIR mHealth and uHealth 7 (11) (2019)

Anna-Maria Dittrich.css-eqlu8i{font-size:small;padding-left:4px;} (Anna M Dittrich)

Publication Activity (10 Years)

Top Topics

Top Venues

Anna-Maria Dittrich (Anna M Dittrich)